Form 4: NHC Director Exercises Options, Boosts Stake
Insider Transaction Report
National Healthcare Corp Director James Paul Abernathy exercised stock options and increased his direct beneficial ownership of common stock.
Summary
- Director James Paul Abernathy exercised 4,010 stock options granted in 2021 at an exercise price of $71.64 per share.
- Following the exercise, 2,639 shares were withheld by National Healthcare Corp at a price of $108.82 per share to cover the exercise price and/or tax liabilities.
- Abernathy's direct beneficial ownership of National Healthcare Corp common stock increased by a net of 1,371 shares (4,010 acquired 2,639 withheld) as a result of these transactions.
- His total direct beneficial ownership of common stock is now 36,394 shares.
- He continues to hold 30,000 unexercised stock options from 2022, 2023, 2024, and 2025 grants.
Sentiment
Score: 7
Explanation: The director's net increase in share ownership, albeit modest after tax withholding, indicates continued confidence in the company. The exercise of in-the-money options is a positive sign for the director, reflecting personal gain and alignment with shareholder interests.
Positives
- Director Abernathy increased his direct beneficial ownership of common stock by a net of 1,371 shares, signaling continued confidence in the company.
- The exercise price of $71.64 for the 2021 options was significantly lower than the $108.82 market price at which shares were withheld, indicating a profitable exercise for the director.
Negatives
- A significant portion of the acquired shares (2,639 out of 4,010) were immediately disposed of to cover exercise costs and taxes, reducing the net increase in direct ownership.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- The transactions involve the exercise of stock options granted under the company's 2020 Omnibus Equity Incentive Plan, which is a standard form of compensation for directors and is considered a related party transaction.
Stakeholder Impact
- Shareholders: The director's increased ownership aligns his interests more closely with shareholders.
- Employees: The equity incentive plan provides a framework for employee and director compensation.
Next Steps
- Remaining unexercised stock options from 2022, 2023, 2024, and 2025 grants will become exercisable on their respective vesting dates and expire on their respective expiration dates.
Key Dates
| Date | Description |
|---|---|
| 2021-05-06 | Grant date of 4,010 stock options under the 2020 Omnibus Equity Incentive Plan. |
| 2022-05-06 | Date 2021 stock options became exercisable. |
| 2023-05-05 | Date 2022 stock options became exercisable. |
| 2024-05-04 | Date 2023 stock options became exercisable. |
| 2025-05-09 | Date 2024 stock options became exercisable. |
| 2025-08-13 | Date of transaction: Exercise of 4,010 stock options and withholding of 2,639 shares. |
| 2025-08-15 | Signature date of the Form 4 filing. |
| 2026-05-07 | Date 2025 stock options become exercisable. |
| 2026-05-05 | Expiration date of 2021 stock options. |
| 2027-05-04 | Expiration date of 2022 stock options. |
| 2028-05-03 | Expiration date of 2023 stock options. |
| 2029-05-08 | Expiration date of 2024 stock options. |
| 2030-05-07 | Expiration date of 2025 stock options. |
Recommendation
holdThis Form 4 filing details a routine insider transaction where a director exercised stock options and increased their net beneficial ownership. While the increase in ownership is a positive signal of confidence, the transaction itself is not indicative of new fundamental information that would warrant a change in investment recommendation. It primarily reflects compensation realization and personal portfolio management.
Keywords
National Healthcare Corp, NHC, Insider Trading, Form 4, Stock Options, Director Stock Ownership, Equity Incentive Plan, James Paul Abernathy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.